跳至主要内容
临床试验/EUCTR2005-001338-33-IT
EUCTR2005-001338-33-IT进行中(未招募)不适用

A Randomized, Double-Blind, Placebo-Controlled, Fixed Dose-Ranging Study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy for Infants (1 to 23 Months of Age, Inclusive) With Refractory Partial-Onset Seizures, With Open-Label Extension

JANSSEN-CILAG0 个研究点目标入组 240 人开始时间: 2005年11月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
JANSSEN-CILAG
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
JANSSEN-CILAG

相似试验

进行中(未招募)
1 期
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6-Week, Hospitalized Patients, Study to Assess Efficacy and Safety of HP-3070 in Subjects with SchizophreniaSchizophrenia
EUCTR2015-005134-21-SKoven Pharmaceuticals, Inc.617
招募中
1 期
A Randomised, Double-Blind, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ZE46 0134 in Healthy VolunteersCancer - Leukaemia - Acute leukaemiaCancer
ACTRN12623000871640Eilean Therapeutics80
招募中
1 期
A Randomised, Double-Blind, Placebo-Controlled, First-in-Human Study of Orally Administered 83-0060 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy VolunteersSARS-CoV-2Respiratory - Other respiratory disorders / diseases
ACTRN12624000220561Trawsfynydd Therapeutics AU Pty Ltd64
招募中
1 期
A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-002158 to Evaluate the Safety, Tolerability and Pharmacokinetics ofSingle Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending Dosing in Subjects with Chronic Hepatitis C Genotype 1 Infection.Chronic Hepatitis C infectionInfection - Other infectious diseasesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12612000176864CPR Pharma Services78
招募中
不适用
Phase 3 Trial of PED-1 in Male Patients With Premature Ejaculatio
KCT0000199Symyoo180